Scottsdale Healthcare is world

December 8, 2009

By Flinn Foundation

[Source: Scottsdale Healthcare] – TGen Clinical Research Services at Scottsdale Healthcare (TCRS) is the world’s first clinical trials site for a new drug designed to halt cancer cell division.


NMS-1286937 is produced by Nerviano Medical Sciences of Milan, Italy’s largest pharmaceutical research and development facility. NMS-1286937 is designed to stop cancer from spreading by preventing mitosis, the process of cell division.

For more information: Scottsdale Healthcare is world’s first site to test new drug by major Italian pharmaceutical firm